- Home
- MTEX vs OVID Comparison
MTEX vs OVID Comparison
Compare MTEX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- OVID
- Stock Information
- Founded
- MTEX 1993
- OVID 2014
- Country
- MTEX United States
- OVID United States
- Employees
- MTEX N/A
- OVID N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- OVID Health Care
- Exchange
- MTEX Nasdaq
- OVID Nasdaq
- Market Cap
- MTEX 20.0M
- OVID 20.6M
- IPO Year
- MTEX 1999
- OVID 2017
- Fundamental
- Price
- MTEX $8.31
- OVID $0.37
- Analyst Decision
- MTEX
- OVID Strong Buy
- Analyst Count
- MTEX 0
- OVID 4
- Target Price
- MTEX N/A
- OVID $3.13
- AVG Volume (30 Days)
- MTEX 19.2K
- OVID 1.5M
- Earning Date
- MTEX 08-12-2025
- OVID 08-12-2025
- Dividend Yield
- MTEX N/A
- OVID N/A
- EPS Growth
- MTEX N/A
- OVID N/A
- EPS
- MTEX N/A
- OVID N/A
- Revenue
- MTEX $115,036,000.00
- OVID $548,000.00
- Revenue This Year
- MTEX N/A
- OVID N/A
- Revenue Next Year
- MTEX N/A
- OVID $5.32
- P/E Ratio
- MTEX N/A
- OVID N/A
- Revenue Growth
- MTEX N/A
- OVID 15.61
- 52 Week Low
- MTEX $7.00
- OVID $0.24
- 52 Week High
- MTEX $16.49
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- MTEX 39.24
- OVID 54.07
- Support Level
- MTEX $8.40
- OVID $0.30
- Resistance Level
- MTEX $9.90
- OVID $0.44
- Average True Range (ATR)
- MTEX 0.68
- OVID 0.04
- MACD
- MTEX -0.07
- OVID 0.01
- Stochastic Oscillator
- MTEX 9.81
- OVID 46.20
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.